Comprehensive analysis of serum tumor markers and <i>BRCA1/2</i> germline mutations in Chinese ovarian cancer patients

Hongyu Deng(Hunan Cancer Hospital), Jun Wang(Central South University), Yanjie Zhou(Central South University), Julia X. Day, Bin Liu(Zhejiang Chinese Medical University), Yinghua Li(Fudan University), Ming Chen(First Affiliated Hospital Zhejiang University), Xiaochun Wang(Jiangsu University), Lizhong Dai, Jinliang Li(Palo Alto University), Xinwu Guo, Hui Jiang(Hunan Agricultural University), Guoli Li(Nanjing General Hospital of Nanjing Military Command), Limin Peng(Emory University), Xunxun Xu, Jianfu Heng(Central South University), Dongyong Shan(Central South University)
Molecular Genetics & Genomic Medicine
April 10, 2019
10.1002/mgg3.672
Cited by 10

Related Papers

Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery
|Diabetes Care|2010|731
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
|Diabetes Care|2011|716
Characterization of ferroptosis in murine models of hemochromatosis
|Hepatology|2017|669
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLC
|New England Journal of Medicine|2024|291